Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose TMP-SMX prophylaxis for Pneumocystis pneumonia in immunosuppressed rheumatic disease patients
jRCTs051250115Recruiting
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of trimethoprim + sulfamethoxazole in pneumocystis pneumonia (PCP). Started Feb 2026; status: recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
pneumocystis pneumonia (PCP)
Beyond the preview
Go deeper on jRCTs051250115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250115.